Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-14

Clinical Trial Update: Comorbid Obesity and Depression With an Anti-inflammatory Medication [NA]

View source ↗

Summary

A clinical trial at King's College London is recruiting to evaluate an anti-inflammatory medication for individuals with obesity and major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: King's College London | Conditions: Obesity, Major Depressive Disorder | NA | Status: RECRUITING